HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas
This study is ongoing, but not recruiting participants.
Sponsor:
University of Pittsburgh
Collaborators:
Musella Foundation
Information provided by (Responsible Party):
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00874861
First received: April 2, 2009
Last updated: January 6, 2012
Last verified: January 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | April 2015 |
| Estimated Primary Completion Date: | April 2013 (Final data collection date for primary outcome measure) |